Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer.
Grisham RN, Vergote I, Banerjee S, Drill E, Kalbacher E, Mirza MR, Romero I, Vuylsteke P, Coleman RL, Hilpert F, Oza AM, Westermann A, Oehler MK, Pignata S, Aghajanian C, Colombo N, Cibula D, Moore KN, Del Campo JM, Berger R, Marth C, Sehouli J, O'Malley DM, Churruca C, Kristensen G, Clamp A, Farley J, Iyer G, Ray-Coquard I, Monk BJ. Grisham RN, et al. Among authors: hilpert f. Clin Cancer Res. 2023 Oct 13;29(20):4068-4075. doi: 10.1158/1078-0432.CCR-23-0621. Clin Cancer Res. 2023. PMID: 37581616 Free PMC article.
[Advances in the treatment of ovarian carcinoma].
Pfisterer J, du Bois A, Hilpert F, Wagner U, Meier W. Pfisterer J, et al. Among authors: hilpert f. Dtsch Med Wochenschr. 2004 Feb 20;129(8):379-84. doi: 10.1055/s-2004-819897. Dtsch Med Wochenschr. 2004. PMID: 14961446 Review. German. No abstract available.
Docetaxel and carboplatin as first-line chemotherapy in patients with advanced gynecological tumors. A phase I/II trial of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group.
Pfisterer J, du Bois A, Wagner U, Quaas J, Blohmer JU, Wallwiener D, Hilpert F; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group. Pfisterer J, et al. Among authors: hilpert f. Gynecol Oncol. 2004 Mar;92(3):949-56. doi: 10.1016/j.ygyno.2003.12.004. Gynecol Oncol. 2004. PMID: 14984965 Clinical Trial.
Clinical picture: nail changes secondary to docetaxel.
Wasner G, Hilpert F, Baron R, Pfisterer J. Wasner G, et al. Among authors: hilpert f. Lancet. 2001 Mar 24;357(9260):910. doi: 10.1016/s0140-6736(00)04210-0. Lancet. 2001. PMID: 11289346 No abstract available.
Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study.
Klapdor R, Wölber L, Hanker L, Schmalfeldt B, Canzler U, Fehm T, Luyten A, Hellriegel M, Kosse J, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Jückstock J, Hilpert F, de Gregorio N, Hillemanns P, Fürst ST, Mahner S. Klapdor R, et al. Among authors: hilpert f. Gynecol Oncol. 2019 Sep;154(3):565-570. doi: 10.1016/j.ygyno.2019.06.013. Epub 2019 Jun 18. Gynecol Oncol. 2019. PMID: 31227222
160 results